Study of neuroblastoma patients assigned to the appropriate treatment group based on the age, tumor stage and biologic features
A tumor may not need treatment until it progresses, observation may be sufficient. Measuring biomarkers in tumor cells help plan future care
Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Neuroblastoma Cyclophosphamide Carboplatin Doxorubicin Liposomal doxorubicin Etoposide Etoposide phosphate Podophyllotoxin Clinical Observation Doxorubicin Hydrochloride Laboratory Biomarker Analysis Pharmacological Study
Lead Scientists at UC Cancer
- Carla B. Golden (ucsf)
Professor, Pediatrics. Authored (or co-authored) 6 research publications.
- Marcio H. Malogolowkin (ucdavis)
Professor, General Pediatrics. Authored (or co-authored) 93 research publications.
- Arun A. Rangaswami (ucsf)
Professor, Pediatrics. Authored (or co-authored) 22 research publications.
- accepting new patients
- Start Date
- Children's Oncology Group
- Phase 3
- Study Type
- Last Updated